Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
16401
16402
16403
16404
16405
16406
16407
16408
16409
16410
16411
16412
16413
16414
16415
16416
16417
16418
16419
16420
16421
16422
16423
16424
16425
16426
16427
16428
16429
16430
16431
16432
16433
16434
16435
16436
16437
16438
16439
16440
16441
16442
16443
16444
16445
16446
16447
16448
16449
16450
16451
16452
16453
16454
16455
16456
16457
16458
16459
16460
16461
16462
16463
16464
16465
16466
16467
16468
16469
16470
16471
16472
16473
16474
16475
16476
16477
16478
16479
16480
16481
16482
16483
16484
16485
16486
16487
16488
16489
16490
16491
16492
16493
16494
16495
16496
16497
16498
16499
16500
16501
16502
16503
16504
16505
16506
16507
16508
16509
16510
16511
16512
16513
16514
16515
16516
16517
16518
16519
16520
16521
16522
16523
16524
16525
16526
16527
16528
16529
16530
16531
16532
16533
16534
16535
16536
16537
16538
16539
16540
16541
16542
16543
16544
16545
16546
16547
16548
16549
16550
16551
16552
16553
16554
16555
16556
16557
16558
16559
16560
16561
16562
16563
16564
16565
16566
16567
16568
16569
16570
16571
16572
16573
16574
16575
16576
16577
16578
16579
16580
16581
16582
16583
16584
16585
16586
16587
16588
16589
16590
16591
16592
16593
16594
16595
16596
16597
16598
16599
16600
| UnnamedSample_HQ_transcript/57846|m.15623 | UnnamedSample_HQ_transcript/57846 | Coverage 0.092 too low. | e9de687d48b94ac53131a4a361b0dacd | 596 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 5.1E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/96954|m.22223 | UnnamedSample_HQ_transcript/96954 | Coverage 0.929 too low. | e29d7df135c8b8834136c34a8993895e | 300 | Pfam | PF05199 | GMC oxidoreductase | 139 | 283 | 7.2E-39 | T | 22-09-2020 | IPR007867 | Glucose-methanol-choline oxidoreductase, C-terminal |
| UnnamedSample_HQ_transcript/96954|m.22223 | UnnamedSample_HQ_transcript/96954 | Coverage 0.929 too low. | e29d7df135c8b8834136c34a8993895e | 300 | Pfam | PF00732 | GMC oxidoreductase | 1 | 32 | 5.3E-6 | T | 22-09-2020 | IPR000172 | Glucose-methanol-choline oxidoreductase, N-terminal |
| UnnamedSample_HQ_transcript/28221|m.9020 | UnnamedSample_HQ_transcript/28221 | Coverage 0.864 too low. | b7e90c76f4db0dfa65ddd6cf5a8a03f4 | 813 | Pfam | PF01429 | Methyl-CpG binding domain | 469 | 531 | 6.6E-8 | T | 22-09-2020 | IPR001739 | Methyl-CpG DNA binding |
| UnnamedSample_HQ_transcript/109719|m.23798 | UnnamedSample_HQ_transcript/109719 | Coverage 0.643 too low. | 4cc5e6c4019dd0b6259989e3fbed0a00 | 196 | Pfam | PF17820 | PDZ domain | 32 | 87 | 2.3E-9 | T | 22-09-2020 | IPR041489 | PDZ domain 6 |
| UnnamedSample_HQ_transcript/48829|m.13765 | UnnamedSample_HQ_transcript/48829 | Coverage 0.037 too low. | b60872f423332e68f0ca70036a7ad876 | 551 | Pfam | PF02874 | ATP synthase alpha/beta family, beta-barrel domain | 67 | 133 | 1.7E-18 | T | 22-09-2020 | IPR004100 | ATPase, F1/V1/A1 complex, alpha/beta subunit, N-terminal domain |
| UnnamedSample_HQ_transcript/48829|m.13765 | UnnamedSample_HQ_transcript/48829 | Coverage 0.037 too low. | b60872f423332e68f0ca70036a7ad876 | 551 | Pfam | PF00006 | ATP synthase alpha/beta family, nucleotide-binding domain | 190 | 413 | 1.4E-71 | T | 22-09-2020 | IPR000194 | ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain |
| UnnamedSample_HQ_transcript/48829|m.13765 | UnnamedSample_HQ_transcript/48829 | Coverage 0.037 too low. | b60872f423332e68f0ca70036a7ad876 | 551 | Pfam | PF00306 | ATP synthase alpha/beta chain, C terminal domain | 420 | 545 | 4.2E-47 | T | 22-09-2020 | IPR000793 | ATP synthase, alpha subunit, C-terminal |
| UnnamedSample_HQ_transcript/78296|m.19424 | UnnamedSample_HQ_transcript/78296 | Coverage 0.840 too low. | 633de387dda83e8ad351a046e1412782 | 333 | Pfam | PF14529 | Endonuclease-reverse transcriptase | 112 | 226 | 4.6E-15 | T | 22-09-2020 | IPR005135 | Endonuclease/exonuclease/phosphatase |
| UnnamedSample_HQ_transcript/80553|m.19809 | UnnamedSample_HQ_transcript/80553 | Coverage 0.602 too low. | a199d1ebc58cb22020a849599b05899a | 409 | Pfam | PF00250 | Forkhead domain | 53 | 135 | 5.8E-27 | T | 22-09-2020 | IPR001766 | Fork head domain |
| UnnamedSample_HQ_transcript/80553|m.19809 | UnnamedSample_HQ_transcript/80553 | Coverage 0.602 too low. | a199d1ebc58cb22020a849599b05899a | 409 | Pfam | PF16676 | Transactivation domain of FOXO protein family | 340 | 376 | 8.1E-9 | T | 22-09-2020 | IPR032067 | FOXO protein, transactivation domain |
| UnnamedSample_HQ_transcript/70825|m.18075 | UnnamedSample_HQ_transcript/70825 | Coverage 0.731 too low. | 1065d41329eb3971f8f5948fc70c5938 | 468 | Pfam | PF00240 | Ubiquitin family | 79 | 150 | 2.0E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/70825|m.18075 | UnnamedSample_HQ_transcript/70825 | Coverage 0.731 too low. | 1065d41329eb3971f8f5948fc70c5938 | 468 | Pfam | PF00240 | Ubiquitin family | 231 | 302 | 2.0E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/70825|m.18075 | UnnamedSample_HQ_transcript/70825 | Coverage 0.731 too low. | 1065d41329eb3971f8f5948fc70c5938 | 468 | Pfam | PF00240 | Ubiquitin family | 3 | 74 | 2.0E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/70825|m.18075 | UnnamedSample_HQ_transcript/70825 | Coverage 0.731 too low. | 1065d41329eb3971f8f5948fc70c5938 | 468 | Pfam | PF00240 | Ubiquitin family | 155 | 226 | 2.0E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/70825|m.18075 | UnnamedSample_HQ_transcript/70825 | Coverage 0.731 too low. | 1065d41329eb3971f8f5948fc70c5938 | 468 | Pfam | PF00240 | Ubiquitin family | 383 | 447 | 1.5E-29 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/70825|m.18075 | UnnamedSample_HQ_transcript/70825 | Coverage 0.731 too low. | 1065d41329eb3971f8f5948fc70c5938 | 468 | Pfam | PF00240 | Ubiquitin family | 307 | 378 | 2.0E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/27925|m.8949 | UnnamedSample_HQ_transcript/27925 | Coverage 0.639 too low. | 00ee321fe3809097b9739e32e2513b9e | 586 | Pfam | PF13246 | Cation transport ATPase (P-type) | 1 | 109 | 2.9E-18 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/27925|m.8949 | UnnamedSample_HQ_transcript/27925 | Coverage 0.639 too low. | 00ee321fe3809097b9739e32e2513b9e | 586 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 366 | 569 | 1.0E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/27925|m.8949 | UnnamedSample_HQ_transcript/27925 | Coverage 0.639 too low. | 00ee321fe3809097b9739e32e2513b9e | 586 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 174 | 296 | 4.7E-15 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/30882|m.9673 | UnnamedSample_HQ_transcript/30882 | Coverage 0.827 too low. | 00ee321fe3809097b9739e32e2513b9e | 586 | Pfam | PF13246 | Cation transport ATPase (P-type) | 1 | 109 | 2.9E-18 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/30882|m.9673 | UnnamedSample_HQ_transcript/30882 | Coverage 0.827 too low. | 00ee321fe3809097b9739e32e2513b9e | 586 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 366 | 569 | 1.0E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/30882|m.9673 | UnnamedSample_HQ_transcript/30882 | Coverage 0.827 too low. | 00ee321fe3809097b9739e32e2513b9e | 586 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 174 | 296 | 4.7E-15 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/27597|m.8859 | UnnamedSample_HQ_transcript/27597 | Coverage 0.637 too low. | bf87e02ff4750641996de3aeda518dc3 | 319 | Pfam | PF01426 | BAH domain | 192 | 311 | 1.1E-13 | T | 22-09-2020 | IPR001025 | Bromo adjacent homology (BAH) domain |
| UnnamedSample_HQ_transcript/38279|m.11459 | UnnamedSample_HQ_transcript/38279 | Coverage 0.582 too low. | bf87e02ff4750641996de3aeda518dc3 | 319 | Pfam | PF01426 | BAH domain | 192 | 311 | 1.1E-13 | T | 22-09-2020 | IPR001025 | Bromo adjacent homology (BAH) domain |
| UnnamedSample_HQ_transcript/45552|m.13048 | UnnamedSample_HQ_transcript/45552 | Coverage 0.538 too low. | bf87e02ff4750641996de3aeda518dc3 | 319 | Pfam | PF01426 | BAH domain | 192 | 311 | 1.1E-13 | T | 22-09-2020 | IPR001025 | Bromo adjacent homology (BAH) domain |
| UnnamedSample_HQ_transcript/63745|m.16787 | UnnamedSample_HQ_transcript/63745 | Coverage 0.777 too low. | bf87e02ff4750641996de3aeda518dc3 | 319 | Pfam | PF01426 | BAH domain | 192 | 311 | 1.1E-13 | T | 22-09-2020 | IPR001025 | Bromo adjacent homology (BAH) domain |
| UnnamedSample_HQ_transcript/53444|m.14729 | UnnamedSample_HQ_transcript/53444 | Coverage 0.499 too low. | bf87e02ff4750641996de3aeda518dc3 | 319 | Pfam | PF01426 | BAH domain | 192 | 311 | 1.1E-13 | T | 22-09-2020 | IPR001025 | Bromo adjacent homology (BAH) domain |
| UnnamedSample_HQ_transcript/15212|m.5467 | UnnamedSample_HQ_transcript/15212 | Coverage 0.703 too low. | bf87e02ff4750641996de3aeda518dc3 | 319 | Pfam | PF01426 | BAH domain | 192 | 311 | 1.1E-13 | T | 22-09-2020 | IPR001025 | Bromo adjacent homology (BAH) domain |
| UnnamedSample_HQ_transcript/74932|m.18819 | UnnamedSample_HQ_transcript/74932 | Unmapped. | 60e19876dbc3f71581eb2acadf22ee52 | 505 | Pfam | PF00910 | RNA helicase | 415 | 505 | 4.4E-15 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/53471|m.14735 | UnnamedSample_HQ_transcript/53471 | Coverage 0.440 too low. | c5f0e14af367bed3489d5f00b576872f | 637 | Pfam | PF07679 | Immunoglobulin I-set domain | 96 | 184 | 9.6E-10 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/3289|m.1561 | UnnamedSample_HQ_transcript/3289 | Coverage 0.066 too low. | 7d95abb03dd3ebacae394852eed491f6 | 1046 | Pfam | PF12203 | Glutamine rich N terminal domain of histone deacetylase 4 | 52 | 135 | 2.9E-6 | T | 22-09-2020 | IPR024643 | Histone deacetylase, glutamine rich N-terminal domain |
| UnnamedSample_HQ_transcript/3289|m.1561 | UnnamedSample_HQ_transcript/3289 | Coverage 0.066 too low. | 7d95abb03dd3ebacae394852eed491f6 | 1046 | Pfam | PF00850 | Histone deacetylase domain | 633 | 950 | 2.6E-85 | T | 22-09-2020 | IPR023801 | Histone deacetylase domain |
| UnnamedSample_HQ_transcript/1899|m.1017 | UnnamedSample_HQ_transcript/1899 | Coverage 0.034 too low. | 547ea8545cf57cafe6b0e2263ac85dca | 635 | Pfam | PF13855 | Leucine rich repeat | 29 | 89 | 6.1E-9 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/1899|m.1017 | UnnamedSample_HQ_transcript/1899 | Coverage 0.034 too low. | 547ea8545cf57cafe6b0e2263ac85dca | 635 | Pfam | PF13855 | Leucine rich repeat | 313 | 368 | 4.3E-7 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/1899|m.1017 | UnnamedSample_HQ_transcript/1899 | Coverage 0.034 too low. | 547ea8545cf57cafe6b0e2263ac85dca | 635 | Pfam | PF13855 | Leucine rich repeat | 219 | 277 | 2.3E-12 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/1899|m.1017 | UnnamedSample_HQ_transcript/1899 | Coverage 0.034 too low. | 547ea8545cf57cafe6b0e2263ac85dca | 635 | Pfam | PF13306 | BspA type Leucine rich repeat region (6 copies) | 371 | 417 | 0.098 | T | 22-09-2020 | IPR026906 | BspA type Leucine rich repeat region |
| UnnamedSample_HQ_transcript/46486|m.13254 | UnnamedSample_HQ_transcript/46486 | Coverage 0.749 too low. | 80caa139a22490b01e7237d063b1a06e | 633 | Pfam | PF00567 | Tudor domain | 187 | 286 | 1.8E-15 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/46486|m.13254 | UnnamedSample_HQ_transcript/46486 | Coverage 0.749 too low. | 80caa139a22490b01e7237d063b1a06e | 633 | Pfam | PF00567 | Tudor domain | 477 | 585 | 5.3E-18 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/18626|m.6476 | UnnamedSample_HQ_transcript/18626 | Coverage 0.151 too low. | 293fb8eb49dc78f861bc451740d537fc | 384 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 239 | 307 | 5.9E-15 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/18626|m.6476 | UnnamedSample_HQ_transcript/18626 | Coverage 0.151 too low. | 293fb8eb49dc78f861bc451740d537fc | 384 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 151 | 219 | 5.5E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/19526|m.6730 | UnnamedSample_HQ_transcript/19526 | Coverage 0.970 too low. | 0ec95bd8b1c8b69b22cbc178a9b64f33 | 566 | Pfam | PF00047 | Immunoglobulin domain | 291 | 365 | 3.5E-11 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/19526|m.6730 | UnnamedSample_HQ_transcript/19526 | Coverage 0.970 too low. | 0ec95bd8b1c8b69b22cbc178a9b64f33 | 566 | Pfam | PF13855 | Leucine rich repeat | 16 | 76 | 4.6E-18 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/19526|m.6730 | UnnamedSample_HQ_transcript/19526 | Coverage 0.970 too low. | 0ec95bd8b1c8b69b22cbc178a9b64f33 | 566 | Pfam | PF07679 | Immunoglobulin I-set domain | 175 | 250 | 3.5E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/19526|m.6730 | UnnamedSample_HQ_transcript/19526 | Coverage 0.970 too low. | 0ec95bd8b1c8b69b22cbc178a9b64f33 | 566 | Pfam | PF07679 | Immunoglobulin I-set domain | 478 | 556 | 3.9E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/19526|m.6730 | UnnamedSample_HQ_transcript/19526 | Coverage 0.970 too low. | 0ec95bd8b1c8b69b22cbc178a9b64f33 | 566 | Pfam | PF07679 | Immunoglobulin I-set domain | 381 | 468 | 2.5E-19 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/89077|m.21096 | UnnamedSample_HQ_transcript/89077 | Coverage 0.948 too low. | 733ff90be4ae751fdc538711f4d1b047 | 184 | Pfam | PF00071 | Ras family | 5 | 165 | 6.5E-58 | T | 22-09-2020 | IPR001806 | Small GTPase |
| UnnamedSample_HQ_transcript/69809|m.17892 | UnnamedSample_HQ_transcript/69809 | Coverage 0.473 too low. | 733ff90be4ae751fdc538711f4d1b047 | 184 | Pfam | PF00071 | Ras family | 5 | 165 | 6.5E-58 | T | 22-09-2020 | IPR001806 | Small GTPase |
| UnnamedSample_HQ_transcript/76731|m.19159 | UnnamedSample_HQ_transcript/76731 | Coverage 0.242 too low. | 2c1e077a64b3ed7141c673ba18d31a5e | 290 | Pfam | PF13903 | PMP-22/EMP/MP20/Claudin tight junction | 16 | 232 | 1.8E-48 | T | 22-09-2020 | IPR004031 | PMP-22/EMP/MP20/Claudin superfamily |
| UnnamedSample_HQ_transcript/66335|m.17277 | UnnamedSample_HQ_transcript/66335 | Coverage 0.301 too low. | 2c1e077a64b3ed7141c673ba18d31a5e | 290 | Pfam | PF13903 | PMP-22/EMP/MP20/Claudin tight junction | 16 | 232 | 1.8E-48 | T | 22-09-2020 | IPR004031 | PMP-22/EMP/MP20/Claudin superfamily |
| UnnamedSample_HQ_transcript/77261|m.19255 | UnnamedSample_HQ_transcript/77261 | Coverage 0.328 too low. | 2c1e077a64b3ed7141c673ba18d31a5e | 290 | Pfam | PF13903 | PMP-22/EMP/MP20/Claudin tight junction | 16 | 232 | 1.8E-48 | T | 22-09-2020 | IPR004031 | PMP-22/EMP/MP20/Claudin superfamily |
| UnnamedSample_HQ_transcript/102375|m.22915 | UnnamedSample_HQ_transcript/102375 | Coverage 0.977 too low. | 42969ff38dbf65d16f97cd9fe3260260 | 125 | Pfam | PF01214 | Casein kinase II regulatory subunit | 7 | 118 | 5.7E-10 | T | 22-09-2020 | IPR000704 | Casein kinase II, regulatory subunit |
| UnnamedSample_HQ_transcript/26432|m.8586 | UnnamedSample_HQ_transcript/26432 | Coverage 0.272 too low. | 0c37258e2d9cc74d28ed49ad3bf4f19d | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 431 | 455 | 3.8E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/26432|m.8586 | UnnamedSample_HQ_transcript/26432 | Coverage 0.272 too low. | 0c37258e2d9cc74d28ed49ad3bf4f19d | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 489 | 511 | 0.0023 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/26432|m.8586 | UnnamedSample_HQ_transcript/26432 | Coverage 0.272 too low. | 0c37258e2d9cc74d28ed49ad3bf4f19d | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 461 | 483 | 2.0E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/26752|m.8665 | UnnamedSample_HQ_transcript/26752 | Coverage 0.413 too low. | cb1be3ba1dc739716f5953e948b26737 | 228 | Pfam | PF14800 | Domain of unknown function (DUF4481) | 25 | 198 | 8.6E-14 | T | 22-09-2020 | IPR028054 | Protein of unknown function DUF4481 |
| UnnamedSample_HQ_transcript/45511|m.13038 | UnnamedSample_HQ_transcript/45511 | Coverage 0.220 too low. | 0444d893a48ceb0a84dd725b7c797f1c | 353 | Pfam | PF00651 | BTB/POZ domain | 61 | 160 | 1.1E-25 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/18119|m.6337 | UnnamedSample_HQ_transcript/18119 | Coverage 0.617 too low. | 0444d893a48ceb0a84dd725b7c797f1c | 353 | Pfam | PF00651 | BTB/POZ domain | 61 | 160 | 1.1E-25 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/27734|m.8896 | UnnamedSample_HQ_transcript/27734 | Coverage 0.984 too low. | 19d28fa7d41feb60ee7db8c64b771451 | 675 | Pfam | PF16534 | Ubiquitin-like oligomerisation domain of SATB | 33 | 139 | 1.8E-26 | T | 22-09-2020 | IPR032392 | SATB, ubiquitin-like oligomerisation domain |
| UnnamedSample_HQ_transcript/27734|m.8896 | UnnamedSample_HQ_transcript/27734 | Coverage 0.984 too low. | 19d28fa7d41feb60ee7db8c64b771451 | 675 | Pfam | PF00046 | Homeodomain | 573 | 639 | 1.5E-8 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/27734|m.8896 | UnnamedSample_HQ_transcript/27734 | Coverage 0.984 too low. | 19d28fa7d41feb60ee7db8c64b771451 | 675 | Pfam | PF00046 | Homeodomain | 268 | 334 | 1.0E-6 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/8058|m.3209 | UnnamedSample_HQ_transcript/8058 | Coverage 0.247 too low. | b33643675c544f627115ecc4bcc00855 | 286 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 37 | 98 | 1.6E-10 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/81427|m.19946 | UnnamedSample_HQ_transcript/81427 | Identity 0.948 too low. | cacce0452f8e63bbb00734d104e60bc2 | 198 | Pfam | PF02535 | ZIP Zinc transporter | 33 | 193 | 1.2E-29 | T | 22-09-2020 | IPR003689 | Zinc/iron permease |
| UnnamedSample_HQ_transcript/70267|m.17968 | UnnamedSample_HQ_transcript/70267 | Identity 0.935 too low. | 453a2488fd869025d80d2434ddc01520 | 527 | Pfam | PF16486 | N-terminal domain of argonaute | 246 | 379 | 9.4E-17 | T | 22-09-2020 | IPR032474 | Protein argonaute, N-terminal |
| UnnamedSample_HQ_transcript/70267|m.17968 | UnnamedSample_HQ_transcript/70267 | Identity 0.935 too low. | 453a2488fd869025d80d2434ddc01520 | 527 | Pfam | PF08699 | Argonaute linker 1 domain | 392 | 438 | 2.2E-11 | T | 22-09-2020 | IPR014811 | Argonaute, linker 1 domain |
| UnnamedSample_HQ_transcript/84477|m.20411 | UnnamedSample_HQ_transcript/84477 | Coverage 0.255 too low. | 8d3b98956517b1cc207a89d6a80b0fe8 | 418 | Pfam | PF00651 | BTB/POZ domain | 23 | 121 | 1.0E-22 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/102774|m.22967 | UnnamedSample_HQ_transcript/102774 | Coverage 0.214 too low. | d59a875174ff667d10a24db0383a2411 | 196 | Pfam | PF17065 | Putative cytokine, C6ORF120 | 23 | 128 | 2.5E-17 | T | 22-09-2020 | IPR031420 | UPF0669 protein C6orf120 |
| UnnamedSample_HQ_transcript/105511|m.23287 | UnnamedSample_HQ_transcript/105511 | Coverage 0.206 too low. | d59a875174ff667d10a24db0383a2411 | 196 | Pfam | PF17065 | Putative cytokine, C6ORF120 | 23 | 128 | 2.5E-17 | T | 22-09-2020 | IPR031420 | UPF0669 protein C6orf120 |
| UnnamedSample_HQ_transcript/26865|m.8685 | UnnamedSample_HQ_transcript/26865 | Coverage 0.164 too low. | 08637381401a5266ada8ae9a370794eb | 655 | Pfam | PF00644 | Poly(ADP-ribose) polymerase catalytic domain | 537 | 655 | 1.0E-44 | T | 22-09-2020 | IPR012317 | Poly(ADP-ribose) polymerase, catalytic domain |
| UnnamedSample_HQ_transcript/26865|m.8685 | UnnamedSample_HQ_transcript/26865 | Coverage 0.164 too low. | 08637381401a5266ada8ae9a370794eb | 655 | Pfam | PF05406 | WGR domain | 285 | 364 | 2.1E-20 | T | 22-09-2020 | IPR008893 | WGR domain |
| UnnamedSample_HQ_transcript/26865|m.8685 | UnnamedSample_HQ_transcript/26865 | Coverage 0.164 too low. | 08637381401a5266ada8ae9a370794eb | 655 | Pfam | PF00645 | Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region | 8 | 82 | 2.5E-15 | T | 22-09-2020 | IPR001510 | Zinc finger, PARP-type |
| UnnamedSample_HQ_transcript/26865|m.8685 | UnnamedSample_HQ_transcript/26865 | Coverage 0.164 too low. | 08637381401a5266ada8ae9a370794eb | 655 | Pfam | PF02877 | Poly(ADP-ribose) polymerase, regulatory domain | 386 | 522 | 1.3E-46 | T | 22-09-2020 | IPR004102 | Poly(ADP-ribose) polymerase, regulatory domain |
| UnnamedSample_HQ_transcript/26865|m.8685 | UnnamedSample_HQ_transcript/26865 | Coverage 0.164 too low. | 08637381401a5266ada8ae9a370794eb | 655 | Pfam | PF08063 | PADR1 (NUC008) domain | 149 | 201 | 3.7E-18 | T | 22-09-2020 | IPR012982 | PADR1 domain |
| UnnamedSample_HQ_transcript/55482|m.15131 | UnnamedSample_HQ_transcript/55482 | Identity 0.803 too low. | 944bf29ca898a681dc133efcc278dc42 | 523 | Pfam | PF07690 | Major Facilitator Superfamily | 71 | 455 | 1.2E-43 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/32062|m.9966 | UnnamedSample_HQ_transcript/32062 | Identity 0.841 too low. | 944bf29ca898a681dc133efcc278dc42 | 523 | Pfam | PF07690 | Major Facilitator Superfamily | 71 | 455 | 1.2E-43 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/39518|m.11748 | UnnamedSample_HQ_transcript/39518 | Identity 0.836 too low. | 944bf29ca898a681dc133efcc278dc42 | 523 | Pfam | PF07690 | Major Facilitator Superfamily | 71 | 455 | 1.2E-43 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/44032|m.12723 | UnnamedSample_HQ_transcript/44032 | Identity 0.828 too low. | 944bf29ca898a681dc133efcc278dc42 | 523 | Pfam | PF07690 | Major Facilitator Superfamily | 71 | 455 | 1.2E-43 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/46298|m.13212 | UnnamedSample_HQ_transcript/46298 | Identity 0.862 too low. | 944bf29ca898a681dc133efcc278dc42 | 523 | Pfam | PF07690 | Major Facilitator Superfamily | 71 | 455 | 1.2E-43 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/44190|m.12759 | UnnamedSample_HQ_transcript/44190 | Identity 0.872 too low. | 944bf29ca898a681dc133efcc278dc42 | 523 | Pfam | PF07690 | Major Facilitator Superfamily | 71 | 455 | 1.2E-43 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/48695|m.13738 | UnnamedSample_HQ_transcript/48695 | Identity 0.822 too low. | 944bf29ca898a681dc133efcc278dc42 | 523 | Pfam | PF07690 | Major Facilitator Superfamily | 71 | 455 | 1.2E-43 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/39660|m.11776 | UnnamedSample_HQ_transcript/39660 | Identity 0.833 too low. | 944bf29ca898a681dc133efcc278dc42 | 523 | Pfam | PF07690 | Major Facilitator Superfamily | 71 | 455 | 1.2E-43 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/43592|m.12616 | UnnamedSample_HQ_transcript/43592 | Identity 0.832 too low. | 944bf29ca898a681dc133efcc278dc42 | 523 | Pfam | PF07690 | Major Facilitator Superfamily | 71 | 455 | 1.2E-43 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/44544|m.12824 | UnnamedSample_HQ_transcript/44544 | Identity 0.825 too low. | 944bf29ca898a681dc133efcc278dc42 | 523 | Pfam | PF07690 | Major Facilitator Superfamily | 71 | 455 | 1.2E-43 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/37688|m.11319 | UnnamedSample_HQ_transcript/37688 | Coverage 0.769 too low. | 0bdd85bd32f0bc1b64124658b8bf54d6 | 342 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 296 | 1.2E-54 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/69903|m.17913 | UnnamedSample_HQ_transcript/69903 | Coverage 0.079 too low. | a940cb9e46c62f91ed4da35e32c38f73 | 440 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 94 | 362 | 4.7E-52 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/7619|m.3060 | UnnamedSample_HQ_transcript/7619 | Coverage 0.156 too low. | b02dc19c03b5ed871e6b0d311b0f7b4a | 1185 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 21 | 102 | 3.9E-15 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/7619|m.3060 | UnnamedSample_HQ_transcript/7619 | Coverage 0.156 too low. | b02dc19c03b5ed871e6b0d311b0f7b4a | 1185 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 186 | 757 | 2.7E-28 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/7619|m.3060 | UnnamedSample_HQ_transcript/7619 | Coverage 0.156 too low. | b02dc19c03b5ed871e6b0d311b0f7b4a | 1185 | Pfam | PF08264 | Anticodon-binding domain of tRNA ligase | 797 | 918 | 4.6E-14 | T | 22-09-2020 | IPR013155 | Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding |
| UnnamedSample_HQ_transcript/0|m.1 | UnnamedSample_HQ_transcript/0 | Unmapped. | 757f02aa9c091c32c42a10393bfc371a | 1370 | Pfam | PF13086 | AAA domain | 21 | 90 | 1.7E-8 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/0|m.1 | UnnamedSample_HQ_transcript/0 | Unmapped. | 757f02aa9c091c32c42a10393bfc371a | 1370 | Pfam | PF13087 | AAA domain | 201 | 372 | 1.2E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/35623|m.10843 | UnnamedSample_HQ_transcript/35623 | Identity 0.921 too low. | 010d81e01559d003c5acb3f4f94118d5 | 118 | Pfam | PF12605 | Casein kinase 1 gamma C terminal | 76 | 100 | 3.5E-10 | T | 22-09-2020 | IPR022247 | Casein kinase 1 gamma C-terminal |
| UnnamedSample_HQ_transcript/70340|m.17985 | UnnamedSample_HQ_transcript/70340 | Coverage 0.290 too low. | b680e081af5aa9ebaef73dfeae7db46a | 351 | Pfam | PF01582 | TIR domain | 106 | 250 | 3.7E-6 | T | 22-09-2020 | IPR000157 | Toll/interleukin-1 receptor homology (TIR) domain |
| UnnamedSample_HQ_transcript/26130|m.8512 | UnnamedSample_HQ_transcript/26130 | Identity 0.903 too low. | 09b3da247be113fe684d8c9dec9b6f9a | 953 | Pfam | PF00567 | Tudor domain | 791 | 871 | 6.2E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/26130|m.8512 | UnnamedSample_HQ_transcript/26130 | Identity 0.903 too low. | 09b3da247be113fe684d8c9dec9b6f9a | 953 | Pfam | PF00567 | Tudor domain | 381 | 491 | 2.0E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/26130|m.8512 | UnnamedSample_HQ_transcript/26130 | Identity 0.903 too low. | 09b3da247be113fe684d8c9dec9b6f9a | 953 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.6E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/37664|m.11313 | UnnamedSample_HQ_transcript/37664 | Coverage 0.133 too low. | 70f43983c0c41efebb578ca264c971ff | 627 | Pfam | PF00069 | Protein kinase domain | 51 | 305 | 3.0E-74 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/95246|m.21990 | UnnamedSample_HQ_transcript/95246 | Coverage 0.970 too low. | d1d33abb9e65f2cf8f0351d204a73699 | 244 | Pfam | PF04824 | Conserved region of Rad21 / Rec8 like protein | 190 | 239 | 1.3E-14 | T | 22-09-2020 | IPR006909 | Rad21/Rec8-like protein, C-terminal, eukaryotic |
| UnnamedSample_HQ_transcript/17475|m.6146 | UnnamedSample_HQ_transcript/17475 | Coverage 0.576 too low. | 55ef121ac151bc5b9bd9eca5d9903720 | 269 | Pfam | PF01770 | Reduced folate carrier | 2 | 269 | 2.8E-87 | T | 22-09-2020 | IPR002666 | Reduced folate carrier |
| UnnamedSample_HQ_transcript/25951|m.8468 | UnnamedSample_HQ_transcript/25951 | Coverage 0.857 too low. | 8c6a908dfed3dcd7881153bc51b6884a | 474 | Pfam | PF01061 | ABC-2 type transporter | 281 | 422 | 5.9E-22 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/25951|m.8468 | UnnamedSample_HQ_transcript/25951 | Coverage 0.857 too low. | 8c6a908dfed3dcd7881153bc51b6884a | 474 | Pfam | PF00005 | ABC transporter | 1 | 133 | 7.0E-24 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/25951|m.8468 | UnnamedSample_HQ_transcript/25951 | Coverage 0.857 too low. | 8c6a908dfed3dcd7881153bc51b6884a | 474 | Pfam | PF19055 | ABC-2 type transporter | 163 | 227 | 1.6E-8 | T | 22-09-2020 | IPR043926 | ABC transporter family G domain |
| UnnamedSample_HQ_transcript/45199|m.12953 | UnnamedSample_HQ_transcript/45199 | Coverage 0.768 too low. | 2a0ef6a67324dd96dac39a1ae7c80dd8 | 372 | Pfam | PF13176 | Tetratricopeptide repeat | 203 | 231 | 1.6E-4 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/45199|m.12953 | UnnamedSample_HQ_transcript/45199 | Coverage 0.768 too low. | 2a0ef6a67324dd96dac39a1ae7c80dd8 | 372 | Pfam | PF13374 | Tetratricopeptide repeat | 283 | 316 | 7.1E-5 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/45199|m.12953 | UnnamedSample_HQ_transcript/45199 | Coverage 0.768 too low. | 2a0ef6a67324dd96dac39a1ae7c80dd8 | 372 | Pfam | PF13424 | Tetratricopeptide repeat | 31 | 105 | 1.2E-17 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/45199|m.12953 | UnnamedSample_HQ_transcript/45199 | Coverage 0.768 too low. | 2a0ef6a67324dd96dac39a1ae7c80dd8 | 372 | Pfam | PF13424 | Tetratricopeptide repeat | 114 | 188 | 2.9E-21 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/88832|m.21058 | UnnamedSample_HQ_transcript/88832 | Coverage 0.826 too low. | e5d662740617c0dc759f22658d38788f | 329 | Pfam | PF16676 | Transactivation domain of FOXO protein family | 260 | 296 | 6.0E-9 | T | 22-09-2020 | IPR032067 | FOXO protein, transactivation domain |
| UnnamedSample_HQ_transcript/88832|m.21058 | UnnamedSample_HQ_transcript/88832 | Coverage 0.826 too low. | e5d662740617c0dc759f22658d38788f | 329 | Pfam | PF00250 | Forkhead domain | 3 | 55 | 3.9E-12 | T | 22-09-2020 | IPR001766 | Fork head domain |
| UnnamedSample_HQ_transcript/16761|m.5934 | UnnamedSample_HQ_transcript/16761 | Unmapped. | ba7f9325b4643f85043a2dd6b75c7644 | 833 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 375 | 744 | 7.1E-10 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/3647|m.1668 | UnnamedSample_HQ_transcript/3647 | Unmapped. | f0df0eecad60a56a3c9279a71bdce6c6 | 1483 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 1117 | 1442 | 2.0E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/3647|m.1668 | UnnamedSample_HQ_transcript/3647 | Unmapped. | f0df0eecad60a56a3c9279a71bdce6c6 | 1483 | Pfam | PF00910 | RNA helicase | 55 | 163 | 5.3E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/78759|m.19512 | UnnamedSample_HQ_transcript/78759 | Coverage 0.957 too low. | 84e124f9e34c53d84c79977aef5dc7bd | 499 | Pfam | PF00012 | Hsp70 protein | 1 | 497 | 5.1E-178 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/81982|m.20027 | UnnamedSample_HQ_transcript/81982 | Coverage 0.783 too low. | c8fa1c6264077b4d41cdede068e7243a | 256 | Pfam | PF10507 | Transmembrane protein 65 | 136 | 241 | 4.9E-44 | T | 22-09-2020 | IPR019537 | Transmembrane protein 65 |
| UnnamedSample_HQ_transcript/60706|m.16199 | UnnamedSample_HQ_transcript/60706 | Coverage 0.986 too low. | 2d139a086e96060b31d0f34e933b1788 | 566 | Pfam | PF00012 | Hsp70 protein | 5 | 565 | 1.6E-210 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/99010|m.22495 | UnnamedSample_HQ_transcript/99010 | Unmapped. | 53344a82d775024197287cfdfcaae762 | 367 | Pfam | PF02774 | Semialdehyde dehydrogenase, dimerisation domain | 144 | 353 | 8.2E-55 | T | 22-09-2020 | IPR012280 | Semialdehyde dehydrogenase, dimerisation domain |
| UnnamedSample_HQ_transcript/99010|m.22495 | UnnamedSample_HQ_transcript/99010 | Unmapped. | 53344a82d775024197287cfdfcaae762 | 367 | Pfam | PF01118 | Semialdehyde dehydrogenase, NAD binding domain | 3 | 121 | 4.3E-24 | T | 22-09-2020 | IPR000534 | Semialdehyde dehydrogenase, NAD-binding |
| UnnamedSample_HQ_transcript/80042|m.19725 | UnnamedSample_HQ_transcript/80042 | Coverage 0.592 too low. | 4eb09e18e74d3e1df32071d211e82c2d | 424 | Pfam | PF00069 | Protein kinase domain | 6 | 76 | 2.7E-9 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/40298|m.11906 | UnnamedSample_HQ_transcript/40298 | Coverage 0.789 too low. | 3c26617eca574f529f43d14c28246909 | 424 | Pfam | PF16040 | Domain of unknown function (DUF4792) | 98 | 167 | 9.5E-22 | T | 22-09-2020 | IPR032008 | Domain of unknown function DUF4792 |
| UnnamedSample_HQ_transcript/2646|m.1296 | UnnamedSample_HQ_transcript/2646 | Identity 0.900 too low. | d47650201c5afc1947e11b766308398a | 1345 | Pfam | PF11502 | B-cell lymphoma 9 protein | 369 | 405 | 5.2E-6 | T | 22-09-2020 | IPR024670 | B-cell lymphoma 9, beta-catenin binding domain |
| UnnamedSample_HQ_transcript/25255|m.8276 | UnnamedSample_HQ_transcript/25255 | Coverage 0.978 too low. | 723df1b287ad28f03114a5022ed0afc1 | 841 | Pfam | PF01590 | GAF domain | 401 | 490 | 1.7E-12 | T | 22-09-2020 | IPR003018 | GAF domain |
| UnnamedSample_HQ_transcript/25255|m.8276 | UnnamedSample_HQ_transcript/25255 | Coverage 0.978 too low. | 723df1b287ad28f03114a5022ed0afc1 | 841 | Pfam | PF01590 | GAF domain | 528 | 673 | 6.3E-15 | T | 22-09-2020 | IPR003018 | GAF domain |
| UnnamedSample_HQ_transcript/25255|m.8276 | UnnamedSample_HQ_transcript/25255 | Coverage 0.978 too low. | 723df1b287ad28f03114a5022ed0afc1 | 841 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 779 | 834 | 3.2E-21 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/26942|m.8702 | UnnamedSample_HQ_transcript/26942 | Identity 0.916 too low. | fa5e5649349a67756d77df6b1f3ba6ae | 574 | Pfam | PF00225 | Kinesin motor domain | 97 | 422 | 7.9E-97 | T | 22-09-2020 | IPR001752 | Kinesin motor domain |
| UnnamedSample_HQ_transcript/71205|m.18151 | UnnamedSample_HQ_transcript/71205 | Coverage 0.067 too low. | f7b0ea997b3282055cbde39ce10b4d12 | 268 | Pfam | PF00085 | Thioredoxin | 30 | 132 | 3.6E-32 | T | 22-09-2020 | IPR013766 | Thioredoxin domain |
| UnnamedSample_HQ_transcript/71205|m.18151 | UnnamedSample_HQ_transcript/71205 | Coverage 0.067 too low. | f7b0ea997b3282055cbde39ce10b4d12 | 268 | Pfam | PF13848 | Thioredoxin-like domain | 162 | 261 | 3.6E-18 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/44379|m.12788 | UnnamedSample_HQ_transcript/44379 | Coverage 0.937 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12925 | E2 domain of amyloid precursor protein | 278 | 466 | 5.8E-78 | T | 22-09-2020 | IPR024329 | Amyloidogenic glycoprotein, E2 domain |
| UnnamedSample_HQ_transcript/44379|m.12788 | UnnamedSample_HQ_transcript/44379 | Coverage 0.937 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12924 | Copper-binding of amyloid precursor, CuBD | 148 | 204 | 4.5E-23 | T | 22-09-2020 | IPR011178 | Amyloidogenic glycoprotein, copper-binding |
| UnnamedSample_HQ_transcript/44379|m.12788 | UnnamedSample_HQ_transcript/44379 | Coverage 0.937 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF02177 | Amyloid A4 N-terminal heparin-binding | 38 | 147 | 5.3E-37 | T | 22-09-2020 | IPR015849 | Amyloidogenic glycoprotein, heparin-binding |
| UnnamedSample_HQ_transcript/44379|m.12788 | UnnamedSample_HQ_transcript/44379 | Coverage 0.937 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF10515 | Beta-amyloid precursor protein C-terminus | 643 | 693 | 7.8E-27 | T | 22-09-2020 | IPR019543 | Beta-amyloid precursor protein C-terminal |
| UnnamedSample_HQ_transcript/31806|m.9897 | UnnamedSample_HQ_transcript/31806 | Coverage 0.898 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12925 | E2 domain of amyloid precursor protein | 278 | 466 | 5.8E-78 | T | 22-09-2020 | IPR024329 | Amyloidogenic glycoprotein, E2 domain |
| UnnamedSample_HQ_transcript/31806|m.9897 | UnnamedSample_HQ_transcript/31806 | Coverage 0.898 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12924 | Copper-binding of amyloid precursor, CuBD | 148 | 204 | 4.5E-23 | T | 22-09-2020 | IPR011178 | Amyloidogenic glycoprotein, copper-binding |
| UnnamedSample_HQ_transcript/31806|m.9897 | UnnamedSample_HQ_transcript/31806 | Coverage 0.898 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF02177 | Amyloid A4 N-terminal heparin-binding | 38 | 147 | 5.3E-37 | T | 22-09-2020 | IPR015849 | Amyloidogenic glycoprotein, heparin-binding |
| UnnamedSample_HQ_transcript/31806|m.9897 | UnnamedSample_HQ_transcript/31806 | Coverage 0.898 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF10515 | Beta-amyloid precursor protein C-terminus | 643 | 693 | 7.8E-27 | T | 22-09-2020 | IPR019543 | Beta-amyloid precursor protein C-terminal |
| UnnamedSample_HQ_transcript/16177|m.5761 | UnnamedSample_HQ_transcript/16177 | Coverage 0.959 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12925 | E2 domain of amyloid precursor protein | 278 | 466 | 5.8E-78 | T | 22-09-2020 | IPR024329 | Amyloidogenic glycoprotein, E2 domain |
| UnnamedSample_HQ_transcript/16177|m.5761 | UnnamedSample_HQ_transcript/16177 | Coverage 0.959 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12924 | Copper-binding of amyloid precursor, CuBD | 148 | 204 | 4.5E-23 | T | 22-09-2020 | IPR011178 | Amyloidogenic glycoprotein, copper-binding |
| UnnamedSample_HQ_transcript/16177|m.5761 | UnnamedSample_HQ_transcript/16177 | Coverage 0.959 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF02177 | Amyloid A4 N-terminal heparin-binding | 38 | 147 | 5.3E-37 | T | 22-09-2020 | IPR015849 | Amyloidogenic glycoprotein, heparin-binding |
| UnnamedSample_HQ_transcript/16177|m.5761 | UnnamedSample_HQ_transcript/16177 | Coverage 0.959 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF10515 | Beta-amyloid precursor protein C-terminus | 643 | 693 | 7.8E-27 | T | 22-09-2020 | IPR019543 | Beta-amyloid precursor protein C-terminal |
| UnnamedSample_HQ_transcript/31533|m.9842 | UnnamedSample_HQ_transcript/31533 | Coverage 0.881 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12925 | E2 domain of amyloid precursor protein | 278 | 466 | 5.8E-78 | T | 22-09-2020 | IPR024329 | Amyloidogenic glycoprotein, E2 domain |
| UnnamedSample_HQ_transcript/31533|m.9842 | UnnamedSample_HQ_transcript/31533 | Coverage 0.881 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12924 | Copper-binding of amyloid precursor, CuBD | 148 | 204 | 4.5E-23 | T | 22-09-2020 | IPR011178 | Amyloidogenic glycoprotein, copper-binding |
| UnnamedSample_HQ_transcript/31533|m.9842 | UnnamedSample_HQ_transcript/31533 | Coverage 0.881 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF02177 | Amyloid A4 N-terminal heparin-binding | 38 | 147 | 5.3E-37 | T | 22-09-2020 | IPR015849 | Amyloidogenic glycoprotein, heparin-binding |
| UnnamedSample_HQ_transcript/31533|m.9842 | UnnamedSample_HQ_transcript/31533 | Coverage 0.881 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF10515 | Beta-amyloid precursor protein C-terminus | 643 | 693 | 7.8E-27 | T | 22-09-2020 | IPR019543 | Beta-amyloid precursor protein C-terminal |
| UnnamedSample_HQ_transcript/38885|m.11598 | UnnamedSample_HQ_transcript/38885 | Coverage 0.877 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12925 | E2 domain of amyloid precursor protein | 278 | 466 | 5.8E-78 | T | 22-09-2020 | IPR024329 | Amyloidogenic glycoprotein, E2 domain |
| UnnamedSample_HQ_transcript/38885|m.11598 | UnnamedSample_HQ_transcript/38885 | Coverage 0.877 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12924 | Copper-binding of amyloid precursor, CuBD | 148 | 204 | 4.5E-23 | T | 22-09-2020 | IPR011178 | Amyloidogenic glycoprotein, copper-binding |
| UnnamedSample_HQ_transcript/38885|m.11598 | UnnamedSample_HQ_transcript/38885 | Coverage 0.877 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF02177 | Amyloid A4 N-terminal heparin-binding | 38 | 147 | 5.3E-37 | T | 22-09-2020 | IPR015849 | Amyloidogenic glycoprotein, heparin-binding |
| UnnamedSample_HQ_transcript/38885|m.11598 | UnnamedSample_HQ_transcript/38885 | Coverage 0.877 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF10515 | Beta-amyloid precursor protein C-terminus | 643 | 693 | 7.8E-27 | T | 22-09-2020 | IPR019543 | Beta-amyloid precursor protein C-terminal |
| UnnamedSample_HQ_transcript/36549|m.11059 | UnnamedSample_HQ_transcript/36549 | Coverage 0.873 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12925 | E2 domain of amyloid precursor protein | 278 | 466 | 5.8E-78 | T | 22-09-2020 | IPR024329 | Amyloidogenic glycoprotein, E2 domain |
| UnnamedSample_HQ_transcript/36549|m.11059 | UnnamedSample_HQ_transcript/36549 | Coverage 0.873 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12924 | Copper-binding of amyloid precursor, CuBD | 148 | 204 | 4.5E-23 | T | 22-09-2020 | IPR011178 | Amyloidogenic glycoprotein, copper-binding |
| UnnamedSample_HQ_transcript/36549|m.11059 | UnnamedSample_HQ_transcript/36549 | Coverage 0.873 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF02177 | Amyloid A4 N-terminal heparin-binding | 38 | 147 | 5.3E-37 | T | 22-09-2020 | IPR015849 | Amyloidogenic glycoprotein, heparin-binding |
| UnnamedSample_HQ_transcript/36549|m.11059 | UnnamedSample_HQ_transcript/36549 | Coverage 0.873 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF10515 | Beta-amyloid precursor protein C-terminus | 643 | 693 | 7.8E-27 | T | 22-09-2020 | IPR019543 | Beta-amyloid precursor protein C-terminal |
| UnnamedSample_HQ_transcript/29015|m.9232 | UnnamedSample_HQ_transcript/29015 | Coverage 0.889 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12925 | E2 domain of amyloid precursor protein | 278 | 466 | 5.8E-78 | T | 22-09-2020 | IPR024329 | Amyloidogenic glycoprotein, E2 domain |
| UnnamedSample_HQ_transcript/29015|m.9232 | UnnamedSample_HQ_transcript/29015 | Coverage 0.889 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12924 | Copper-binding of amyloid precursor, CuBD | 148 | 204 | 4.5E-23 | T | 22-09-2020 | IPR011178 | Amyloidogenic glycoprotein, copper-binding |
| UnnamedSample_HQ_transcript/29015|m.9232 | UnnamedSample_HQ_transcript/29015 | Coverage 0.889 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF02177 | Amyloid A4 N-terminal heparin-binding | 38 | 147 | 5.3E-37 | T | 22-09-2020 | IPR015849 | Amyloidogenic glycoprotein, heparin-binding |
| UnnamedSample_HQ_transcript/29015|m.9232 | UnnamedSample_HQ_transcript/29015 | Coverage 0.889 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF10515 | Beta-amyloid precursor protein C-terminus | 643 | 693 | 7.8E-27 | T | 22-09-2020 | IPR019543 | Beta-amyloid precursor protein C-terminal |
| UnnamedSample_HQ_transcript/35374|m.10795 | UnnamedSample_HQ_transcript/35374 | Coverage 0.945 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12925 | E2 domain of amyloid precursor protein | 278 | 466 | 5.8E-78 | T | 22-09-2020 | IPR024329 | Amyloidogenic glycoprotein, E2 domain |
| UnnamedSample_HQ_transcript/35374|m.10795 | UnnamedSample_HQ_transcript/35374 | Coverage 0.945 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12924 | Copper-binding of amyloid precursor, CuBD | 148 | 204 | 4.5E-23 | T | 22-09-2020 | IPR011178 | Amyloidogenic glycoprotein, copper-binding |
| UnnamedSample_HQ_transcript/35374|m.10795 | UnnamedSample_HQ_transcript/35374 | Coverage 0.945 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF02177 | Amyloid A4 N-terminal heparin-binding | 38 | 147 | 5.3E-37 | T | 22-09-2020 | IPR015849 | Amyloidogenic glycoprotein, heparin-binding |
| UnnamedSample_HQ_transcript/35374|m.10795 | UnnamedSample_HQ_transcript/35374 | Coverage 0.945 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF10515 | Beta-amyloid precursor protein C-terminus | 643 | 693 | 7.8E-27 | T | 22-09-2020 | IPR019543 | Beta-amyloid precursor protein C-terminal |
| UnnamedSample_HQ_transcript/31942|m.9934 | UnnamedSample_HQ_transcript/31942 | Coverage 0.906 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12925 | E2 domain of amyloid precursor protein | 278 | 466 | 5.8E-78 | T | 22-09-2020 | IPR024329 | Amyloidogenic glycoprotein, E2 domain |
| UnnamedSample_HQ_transcript/31942|m.9934 | UnnamedSample_HQ_transcript/31942 | Coverage 0.906 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF12924 | Copper-binding of amyloid precursor, CuBD | 148 | 204 | 4.5E-23 | T | 22-09-2020 | IPR011178 | Amyloidogenic glycoprotein, copper-binding |
| UnnamedSample_HQ_transcript/31942|m.9934 | UnnamedSample_HQ_transcript/31942 | Coverage 0.906 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF02177 | Amyloid A4 N-terminal heparin-binding | 38 | 147 | 5.3E-37 | T | 22-09-2020 | IPR015849 | Amyloidogenic glycoprotein, heparin-binding |
| UnnamedSample_HQ_transcript/31942|m.9934 | UnnamedSample_HQ_transcript/31942 | Coverage 0.906 too low. | bd1b4eb89d16a7a3f2b36bd2c9ffe226 | 696 | Pfam | PF10515 | Beta-amyloid precursor protein C-terminus | 643 | 693 | 7.8E-27 | T | 22-09-2020 | IPR019543 | Beta-amyloid precursor protein C-terminal |
| UnnamedSample_HQ_transcript/37120|m.11197 | UnnamedSample_HQ_transcript/37120 | Coverage 0.509 too low. | 82c162fde47e4db097c510d84213fc3c | 490 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.8E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/37120|m.11197 | UnnamedSample_HQ_transcript/37120 | Coverage 0.509 too low. | 82c162fde47e4db097c510d84213fc3c | 490 | Pfam | PF00046 | Homeodomain | 366 | 421 | 3.3E-20 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/61627|m.16376 | UnnamedSample_HQ_transcript/61627 | Coverage 0.674 too low. | 82c162fde47e4db097c510d84213fc3c | 490 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.8E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/61627|m.16376 | UnnamedSample_HQ_transcript/61627 | Coverage 0.674 too low. | 82c162fde47e4db097c510d84213fc3c | 490 | Pfam | PF00046 | Homeodomain | 366 | 421 | 3.3E-20 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/39598|m.11762 | UnnamedSample_HQ_transcript/39598 | Coverage 0.533 too low. | 82c162fde47e4db097c510d84213fc3c | 490 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.8E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/39598|m.11762 | UnnamedSample_HQ_transcript/39598 | Coverage 0.533 too low. | 82c162fde47e4db097c510d84213fc3c | 490 | Pfam | PF00046 | Homeodomain | 366 | 421 | 3.3E-20 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/77533|m.19296 | UnnamedSample_HQ_transcript/77533 | Unmapped. | 2bdfb253a6577d365802c90ed307a005 | 243 | Pfam | PF03740 | Pyridoxal phosphate biosynthesis protein PdxJ | 5 | 238 | 8.8E-105 | T | 22-09-2020 | IPR004569 | Pyridoxal phosphate (active vitamin B6) biosynthesis PdxJ |
| UnnamedSample_HQ_transcript/80812|m.19837 | UnnamedSample_HQ_transcript/80812 | Unmapped. | 2bdfb253a6577d365802c90ed307a005 | 243 | Pfam | PF03740 | Pyridoxal phosphate biosynthesis protein PdxJ | 5 | 238 | 8.8E-105 | T | 22-09-2020 | IPR004569 | Pyridoxal phosphate (active vitamin B6) biosynthesis PdxJ |
| UnnamedSample_HQ_transcript/17890|m.6266 | UnnamedSample_HQ_transcript/17890 | Identity 0.468 too low. | 6a1c89430bc5cd877a0cd24e2aa9176d | 362 | Pfam | PF01359 | Transposase (partial DDE domain) | 180 | 257 | 9.4E-26 | T | 22-09-2020 | IPR001888 | Transposase, type 1 |
| UnnamedSample_HQ_transcript/17890|m.6266 | UnnamedSample_HQ_transcript/17890 | Identity 0.468 too low. | 6a1c89430bc5cd877a0cd24e2aa9176d | 362 | Pfam | PF17906 | HTH domain in Mos1 transposase | 14 | 58 | 2.3E-6 | T | 22-09-2020 | IPR041426 | Mos1 transposase, HTH domain |
| UnnamedSample_HQ_transcript/71564|m.18218 | UnnamedSample_HQ_transcript/71564 | Coverage 0.884 too low. | e100cd2d594002f477b317ea5b9fc660 | 509 | Pfam | PF05470 | Eukaryotic translation initiation factor 3 subunit 8 N-terminus | 30 | 457 | 1.7E-106 | T | 22-09-2020 | IPR008905 | Eukaryotic translation initiation factor 3 subunit C, N-terminal domain |
| UnnamedSample_HQ_transcript/118561|m.24731 | UnnamedSample_HQ_transcript/118561 | Coverage 0.986 too low. | 52fa0083797fcb03d927cb8e8684577a | 143 | Pfam | PF00253 | Ribosomal protein S14p/S29e | 90 | 142 | 2.6E-13 | T | 22-09-2020 | IPR001209 | Ribosomal protein S14 |
| UnnamedSample_HQ_transcript/48108|m.13607 | UnnamedSample_HQ_transcript/48108 | Identity 0.674 too low. | a02d02c94f49e9e3020588ed1476c665 | 183 | Pfam | PF13639 | Ring finger domain | 7 | 34 | 7.1E-8 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/29517|m.9359 | UnnamedSample_HQ_transcript/29517 | Coverage 0.983 too low. | a2db72856c2bd3e7c4e3f87c8dbffe08 | 793 | Pfam | PF07645 | Calcium-binding EGF domain | 605 | 639 | 3.7E-5 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/29517|m.9359 | UnnamedSample_HQ_transcript/29517 | Coverage 0.983 too low. | a2db72856c2bd3e7c4e3f87c8dbffe08 | 793 | Pfam | PF07645 | Calcium-binding EGF domain | 657 | 686 | 9.2E-4 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/13704|m.5015 | UnnamedSample_HQ_transcript/13704 | Coverage 0.319 too low. | 72eb5de7d4f471c2a401b9195c4d815f | 702 | Pfam | PF00907 | T-box | 140 | 320 | 3.1E-84 | T | 22-09-2020 | IPR001699 | Transcription factor, T-box |
| UnnamedSample_HQ_transcript/13704|m.5015 | UnnamedSample_HQ_transcript/13704 | Coverage 0.319 too low. | 72eb5de7d4f471c2a401b9195c4d815f | 702 | Pfam | PF11078 | Optomotor-blind protein N-terminal region | 79 | 128 | 5.6E-8 | T | 22-09-2020 | IPR021101 | Optomotor-blind protein, N-terminal |
| UnnamedSample_HQ_transcript/12433|m.4637 | UnnamedSample_HQ_transcript/12433 | Coverage 0.326 too low. | 72eb5de7d4f471c2a401b9195c4d815f | 702 | Pfam | PF00907 | T-box | 140 | 320 | 3.1E-84 | T | 22-09-2020 | IPR001699 | Transcription factor, T-box |
| UnnamedSample_HQ_transcript/12433|m.4637 | UnnamedSample_HQ_transcript/12433 | Coverage 0.326 too low. | 72eb5de7d4f471c2a401b9195c4d815f | 702 | Pfam | PF11078 | Optomotor-blind protein N-terminal region | 79 | 128 | 5.6E-8 | T | 22-09-2020 | IPR021101 | Optomotor-blind protein, N-terminal |
| UnnamedSample_HQ_transcript/59551|m.15966 | UnnamedSample_HQ_transcript/59551 | Coverage 0.782 too low. | 805333b0db11c92821d7af1a44a3a406 | 524 | Pfam | PF00067 | Cytochrome P450 | 42 | 520 | 1.3E-81 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/68371|m.17649 | UnnamedSample_HQ_transcript/68371 | Coverage 0.860 too low. | 805333b0db11c92821d7af1a44a3a406 | 524 | Pfam | PF00067 | Cytochrome P450 | 42 | 520 | 1.3E-81 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/68709|m.17711 | UnnamedSample_HQ_transcript/68709 | Coverage 0.838 too low. | 805333b0db11c92821d7af1a44a3a406 | 524 | Pfam | PF00067 | Cytochrome P450 | 42 | 520 | 1.3E-81 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/38446|m.11493 | UnnamedSample_HQ_transcript/38446 | Coverage 0.480 too low. | 71f8bf5c5f062bde3180640201711dd7 | 707 | Pfam | PF08368 | FAST kinase-like protein, subdomain 2 | 597 | 678 | 9.8E-14 | T | 22-09-2020 | IPR013579 | FAST kinase-like protein, subdomain 2 |
| UnnamedSample_HQ_transcript/121768|m.24976 | UnnamedSample_HQ_transcript/121768 | Coverage 0.965 too low. | 878d4a44486ad97147ebfc4372840bbe | 109 | Pfam | PF12248 | Farnesoic acid 0-methyl transferase | 50 | 109 | 7.7E-14 | T | 22-09-2020 | IPR022041 | Farnesoic acid O-methyl transferase |
| UnnamedSample_HQ_transcript/27352|m.8801 | UnnamedSample_HQ_transcript/27352 | Coverage 0.316 too low. | 4f313918608d2b6c09c899341e4d2231 | 231 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 83 | 214 | 1.5E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/29706|m.9402 | UnnamedSample_HQ_transcript/29706 | Coverage 0.806 too low. | 7cb17c25d3bff026bcd7e2ffd72e2525 | 782 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 18 | 306 | 7.0E-19 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/36268|m.10994 | UnnamedSample_HQ_transcript/36268 | Coverage 0.869 too low. | 7cb17c25d3bff026bcd7e2ffd72e2525 | 782 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 18 | 306 | 7.0E-19 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/50626|m.14155 | UnnamedSample_HQ_transcript/50626 | Coverage 0.438 too low. | bcb7536e287db96edfc15fd16f0d13a9 | 285 | Pfam | PF00628 | PHD-finger | 234 | 280 | 3.5E-13 | T | 22-09-2020 | IPR019787 | Zinc finger, PHD-finger |
| UnnamedSample_HQ_transcript/26255|m.8544 | UnnamedSample_HQ_transcript/26255 | Coverage 0.822 too low. | 293027c12d6755d6d9bcbbd713bf889b | 586 | Pfam | PF00786 | P21-Rho-binding domain | 73 | 128 | 6.7E-24 | T | 22-09-2020 | IPR000095 | CRIB domain |
| UnnamedSample_HQ_transcript/26255|m.8544 | UnnamedSample_HQ_transcript/26255 | Coverage 0.822 too low. | 293027c12d6755d6d9bcbbd713bf889b | 586 | Pfam | PF00069 | Protein kinase domain | 308 | 559 | 6.5E-75 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/32753|m.10151 | UnnamedSample_HQ_transcript/32753 | Coverage 0.773 too low. | 293027c12d6755d6d9bcbbd713bf889b | 586 | Pfam | PF00786 | P21-Rho-binding domain | 73 | 128 | 6.7E-24 | T | 22-09-2020 | IPR000095 | CRIB domain |
| UnnamedSample_HQ_transcript/32753|m.10151 | UnnamedSample_HQ_transcript/32753 | Coverage 0.773 too low. | 293027c12d6755d6d9bcbbd713bf889b | 586 | Pfam | PF00069 | Protein kinase domain | 308 | 559 | 6.5E-75 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/10457|m.3975 | UnnamedSample_HQ_transcript/10457 | Coverage 0.850 too low. | 293027c12d6755d6d9bcbbd713bf889b | 586 | Pfam | PF00786 | P21-Rho-binding domain | 73 | 128 | 6.7E-24 | T | 22-09-2020 | IPR000095 | CRIB domain |
| UnnamedSample_HQ_transcript/10457|m.3975 | UnnamedSample_HQ_transcript/10457 | Coverage 0.850 too low. | 293027c12d6755d6d9bcbbd713bf889b | 586 | Pfam | PF00069 | Protein kinase domain | 308 | 559 | 6.5E-75 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/12570|m.4684 | UnnamedSample_HQ_transcript/12570 | Coverage 0.877 too low. | 293027c12d6755d6d9bcbbd713bf889b | 586 | Pfam | PF00786 | P21-Rho-binding domain | 73 | 128 | 6.7E-24 | T | 22-09-2020 | IPR000095 | CRIB domain |
| UnnamedSample_HQ_transcript/12570|m.4684 | UnnamedSample_HQ_transcript/12570 | Coverage 0.877 too low. | 293027c12d6755d6d9bcbbd713bf889b | 586 | Pfam | PF00069 | Protein kinase domain | 308 | 559 | 6.5E-75 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/48565|m.13711 | UnnamedSample_HQ_transcript/48565 | Coverage 0.807 too low. | 293027c12d6755d6d9bcbbd713bf889b | 586 | Pfam | PF00786 | P21-Rho-binding domain | 73 | 128 | 6.7E-24 | T | 22-09-2020 | IPR000095 | CRIB domain |
| UnnamedSample_HQ_transcript/48565|m.13711 | UnnamedSample_HQ_transcript/48565 | Coverage 0.807 too low. | 293027c12d6755d6d9bcbbd713bf889b | 586 | Pfam | PF00069 | Protein kinase domain | 308 | 559 | 6.5E-75 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/18311|m.6396 | UnnamedSample_HQ_transcript/18311 | Coverage 0.825 too low. | 293027c12d6755d6d9bcbbd713bf889b | 586 | Pfam | PF00786 | P21-Rho-binding domain | 73 | 128 | 6.7E-24 | T | 22-09-2020 | IPR000095 | CRIB domain |
| UnnamedSample_HQ_transcript/18311|m.6396 | UnnamedSample_HQ_transcript/18311 | Coverage 0.825 too low. | 293027c12d6755d6d9bcbbd713bf889b | 586 | Pfam | PF00069 | Protein kinase domain | 308 | 559 | 6.5E-75 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
